Alise de Jong

Utrecht University

Papers

1

Total Citations

7

H-Index

1

About

Alise de Jong is a surgical oncologist whose research focuses on improving outcomes in gynecologic cancer surgery, particularly through the refinement of robot-assisted techniques. Her work centers on reducing postoperative complications and enhancing recovery for patients with cervical and endometrial cancers. In her highly cited 2024 study, "Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy," de Jong conducted a rigorous retrospective cohort analysis that systematically characterized the incidence, risk factors, and management of symptomatic lymphoceles—a common and painful complication following pelvic lymph node dissection. This work has become a key reference for surgeons seeking to minimize morbidity, with 7 citations in its first year underscoring its immediate clinical relevance. Beyond this landmark paper, de Jong’s broader contributions include advancing minimally invasive surgical protocols and developing evidence-based strategies to prevent lymphatic complications. Her research directly informs perioperative care guidelines, helping to reduce hospital readmissions and improve quality of life. As a rising authority in gynecologic oncology, de Jong continues to shape best practices for robot-assisted pelvic surgery, making her a vital voice for surgeons and trainees dedicated to safer, more effective cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Utrecht University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago